Post-COVID Lung Disease Shares Origins with Other Scarring Lung Disorders
UC San Diego HealthUC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
UC San Diego researchers provide first insights into the fundamental cellular pathologies that drive interstitial lung disease in patients post-COVID.
Hospitals and homes are havens for germs and disease – but a well-regulated hot water system can prevent the spread of waterborne pathogens, including an emerging infectious disease problem from ‘superbugs’ which can be resistant to most antibiotics.
An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chances of death, according to a new study from UTHealth Houston and other institutions.
Paramyxoviruses have the potential to trigger a devastating pandemic. This family of viruses includes measles, Nipah virus, mumps, Newcastle disease and canine distemper. An international team of collaborators has published the first-ever look at a key stage in the life cycles of measles and Nipah viruses. It reveals how future therapies might stop these viruses in their tracks.
Those widely available COVID-19 vaccinations keeping the majority of the population free from serious illness will not be enough to stop the spread of the virus and its variants, new University of Virginia collaborative research indicates.
Researchers in Switzerland and the UK have found that in COVID-19 isolation wards less transmission of the virus occurred between patients and healthcare workers than expected, according to a study published today in eLife.
Skin swabs are "surprisingly effective" at identifying Covid-19 infection, according to new research from the University of Surrey, offering a route to a non-invasive future for Covid-19 testing.
A while ago, some researchers had suggested that blocking a set of proteins, known as bromodomain and extraterminal (BET) proteins, might be a way to fight COVID-19.
Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months, according to new clinical trial data.
Disease risk returns to baseline after 23 weeks for diabetes, and 7 weeks for cardiovascular diseases.
As new Omicron subvariants of COVID-19 continue to sweep across the United States, researchers at the University of Missouri have identified specific mutations within the virus’ spike protein that help Omicron subvariants evade existing antibodies humans have from either vaccines or previous COVID-19 infections.
A new study involving hospitalized women in 6 African countries from the University of Maryland School of Medicine’s Institute of Human Virology showed that pregnant women with SARS-CoV-2 had 2X the risk of being admitted to the ICU and 4X the risk of dying than pregnant women who didn't have COVID-19.
Using skin biopsy samples, investigators found that patients with severe COVID-19 had clots in small venous and arterial blood vessels in skin that appears normal.
Viral DNA can be frequently detected in different clinical samples from monkeypox-infected patients, including saliva and semen, according to a new study led by the Barcelona Institute for Global Health (ISGlobal), a centre supported by the "la Caixa" Foundation, and the Hospital Clínic of Barcelona.
Like the coronavirus pandemic, misinformation about monkeypox is mounting along with the number of cases. A Penn State Health infectious disease doctor cuts through the white noise in this week’s Medical Minute.
Thousands of people experiencing the debilitating symptoms of long covid are travelling abroad to seek costly but unproven treatments such as “blood washing”, according to an investigation carried out by The BMJ and ITV News released today.
Summertime trips to lakes or pools to escape the heat can sometimes lead to ear infections caused by excess moisture in the ear canal. Hongzhao Ji, M.D., Assistant Professor of Otolaryngology – Head and Neck Surgery at UT Southwestern, offers information on swimmer’s ear, how to treat it, and how to prevent it.
An array of new, simple “shelf-available” SARS-CoV-2 treatment options could soon be available in the fight against COVID thanks to a new study, “Engineered ACE2-Fc counters murine lethal SARS-CoV-2 infection through direct neutralization and Fc-effector activities,” published July 13 in Science Advances.
A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no symptomatic or clinical benefit to taking fluticasone furoate for the treatment of mild-to-moderate COVID-19 symptoms.
To develop new COVID-19 medications, researchers are working to target nsp13, a protein coronaviruses need to replicate. In ACS Infectious Diseases, researchers describe a new approach to identifying molecules that interfere with this protein, a step toward developing pan-coronavirus antivirals.
Scientists have uncovered an intriguing new understanding of how viruses and the hosts they infect evolve new innovations to outcompete each other. Culminating a 10-year research effort, the researchers tracked the way fitness landscapes constantly change in the ongoing struggle for survival.
When infants breastfeed, they receive an immune boost that helps them fight off infectious diseases, according to recent research from Binghamton University, State University of New York.
Most patients in the study mounted immune responses after a booster dose, and no patient with antibody responses died from COVID-19.
Researchers at the Case Western Reserve University School of Dental Medicine will use a $3.25 million grant from the National Institutes of Health (NIH) to better understand how HIV impacts the human body, from mouth lesions to oral cancer.
Mayo Clinic Laboratories can now test for monkeypox, a rare viral infection, using the Centers for Disease Control and Prevention's (CDC) orthopoxvirus test kit.
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.
Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.
UC San Diego researchers say they may have found the reason why multiple human clinical trials of staphylococcus vaccines have failed: the bacteria knows us too well.
Scientists and physicians at UC San Diego and Scripps Research describe how wastewater sequencing provided dramatic new insights into levels and variants of SARS-CoV-2 on campus and in the broader community — a key step to public health interventions in advance of COVID-19 case surges.
Below are summaries of recent Fred Hutchinson Cancer Center research findings and other news.
Experts Encourage Rapid Genomic Screenings and Development of New Therapeutics for Drug-Resistant Pathogens to Address Emerging Global Health Concern
A new type of vaccine provides protection against a variety of SARS-like betacoronaviruses, including SARS-CoV-2 variants, in mice and monkeys, according to a study led by researchers in the laboratory of Caltech's Pamela Bjorkman, the David Baltimore Professor of Biology and Bioengineering.
Screening sperm for new mutations may help fertility doctors reduce the likelihood of a prospective father passing along a mutation that causes a miscarriage or a congenital disease in their offspring.
Researchers have created an inhalable COVID-19 vaccine that is shelf stable at room temperature for up to three months, targets the lungs specifically and effectively, and allows for self-administration via an inhaler.
A new type of vaccine provides protection against a variety of SARS-like betacoronaviruses, including SARS-CoV-2 variants, in mice and monkeys, according to a study led by researchers in the laboratory of Caltech's Pamela Bjorkman, the David Baltimore Professor of Biology and Bioengineering.
A new study reveals why a highly infectious variant of the cholera bug, which caused large disease outbreaks in the early 1990s, did not cause the eighth cholera pandemic as feared – but instead unexpectedly disappeared.
Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system’s history with other coronaviruses, including those behind the common cold, shapes the patient’s response, according to a recently published study published in Cell Reports.
New research from the University of Georgia suggests age and risk perception may have as much of an effect on COVID-19 vaccine acceptance as party affiliation.
A COVID CommUNITY – South Asian study, published in the Canadian Medical Association Journal (CMAJ) Open has found that South Asian communities living in the Greater Toronto Area (GTA) suffered disproportionately from COVID-19 in the first year of the pandemic.
Columbia University’s Global Alliance for Preventing Pandemics announces an agreement with the University of Zambia’s School of Veterinary Medicine and the U.S. Center for Disease Control and Prevention to train Zambian public health professionals to better identify and contain pathogen outbreaks.
PhD in Public Health student examined disease trends and potential impacts of COVID-19 in northern Syria, underscores the need for enhanced infectious disease surveillance in areas facing humanitarian crisis to reduce the global spread of disease. Parts of the world facing conflict and humanitarian disaster tend to experience a high burden of disease, but their disease monitoring systems remain largely understudied.
Research from a new study suggests that health anxiety among the clinically vulnerable groups who shielded at home has risen since the first pandemic wave, despite developments in viral treatment and the roll-out of the vaccination programme.
UC San Diego researchers have created a mathematical model to help predict risk of anal cancer in persons with HIV infection and aid patients and doctors regarding screening decisions.
The experts agree — the pandemic is not over. Infections are ticking up again, fueled by the new variants our immune systems are ill prepared for.
Despite significant and stunning advances in vaccine technology, the COVID-19 global pandemic is not over.
As you’re enjoying the early fall weather and outdoor adventures, like hiking, don’t forget to make safety a priority to help keep illness and injuries from spoiling family fun time. Jeffrey M. Bender, MD, attending physician in the Division of Infectious Diseases at Children’s Hospital Los Angeles and former ranger in the Sierra Mountains, points out tips on how to prevent bug bites, proper animal interaction and empowering kids to explore the outdoors in a safe and smart way.
Some public venues may need better ventilation to prevent the spread of covid-19 following growing evidence of the potential for ‘long distance’ airborne transmission of the disease, suggests research published by The BMJ today.
In just a few hours, UT Southwestern scientists can tell which variant has infected a COVID-19 patient – a critical task that can potentially influence treatment decisions but takes days or weeks at most medical centers.